Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.2%

2 terminated/withdrawn out of 48 trials

Success Rate

86.7%

+0.2% vs industry average

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed trials have results

Key Signals

16 recruiting2 with results

Enrollment Performance

Analytics

N/A
31(93.9%)
Phase 3
1(3.0%)
Early Phase 1
1(3.0%)
33Total
N/A(31)
Phase 3(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (48)

Showing 20 of 48 trials
NCT06099015Recruiting

Cera™ Vascular Plug System Post-Market Clinical Follow-Up

Role: lead

NCT07529028Not ApplicableNot Yet Recruiting

Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy

Role: lead

NCT05864560Active Not Recruiting

Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up

Role: lead

NCT03601039Not ApplicableCompleted

Safety and Efficacy Study of Absnow Absorbable ASD Closure System For Treating ASD Patients

Role: lead

NCT07455539Not ApplicableNot Yet Recruiting

LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation

Role: collaborator

NCT06465459Recruiting

Post-marketing Clinical Study of the LAMBRE System for Left Auricle Closure

Role: collaborator

NCT07385599Not ApplicableActive Not Recruiting

FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients

Role: lead

NCT06120270Recruiting

CeraFlex PFO Closure System PMCF Study

Role: lead

NCT04684212Not ApplicableWithdrawn

Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF

Role: collaborator

NCT06710938Not ApplicableRecruiting

Thoracoabdominal Artery Stent Graft System Exploratory Study

Role: lead

NCT06520774Not ApplicableRecruiting

Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases

Role: lead

NCT03666780Completed

Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study

Role: lead

NCT05639569Recruiting

Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study

Role: lead

NCT05054985Not ApplicableRecruiting

Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm.

Role: lead

NCT05803564Not ApplicableRecruiting

Thoracoabdominal Aortic Stent System for Endovascular Treatment of Thoracoabdominal Aortic Dissecting Aneurysm.

Role: lead

NCT03767777Not ApplicableCompleted

Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY(PATENCY)

Role: lead

NCT06915545Not ApplicableRecruiting

Study on the Aortic Arch Single Branch Stent Graft System

Role: lead

NCT03509142Not ApplicableCompleted

A First-in-Man Study of IBS

Role: lead

NCT06849635Recruiting

Cera™ ASD Occluder Post-Market Clinical Follow-Up Study

Role: lead

NCT05887700Recruiting

Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up

Role: lead